Stage IA Breast Cancer Completed Phase 3 Trials for Paclitaxel (DB01229)

IndicationStatusPhase
DBCOND0029217 (Stage IA Breast Cancer)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00513292Combination Chemotherapy and Paclitaxel Plus Trastuzumab in Treating Women With Palpable Breast Cancer That Can Be Removed by SurgeryTreatment